Edition:
United States

Illumina Inc (ILMN.O)

ILMN.O on Nasdaq

212.18USD
14 Dec 2017
Change (% chg)

$-2.37 (-1.10%)
Prev Close
$214.55
Open
$215.06
Day's High
$215.80
Day's Low
$211.98
Volume
206,184
Avg. Vol
753,890
52-wk High
$230.72
52-wk Low
$124.82

Latest Key Developments (Source: Significant Developments)

Disney Board Elects Oracle And Illumina CEOs As Directors
Thursday, 7 Dec 2017 04:15pm EST 

Dec 7 (Reuters) - Walt Disney Co ::DISNEY BOARD ELECTS ORACLE’S SAFRA CATZ AND ILLUMINA’S FRANCIS A. DESOUZA AS DIRECTORS.WALT DISNEY CO - ELECTIONS OF CATZ AND DESOUZA ARE EFFECTIVE FEBRUARY 1, 2018.WALT DISNEY CO - ELECTION OF 2 NEW DIRECTORS: SAFRA CATZ, CEO OF ORACLE, AND FRANCIS DESOUZA, CEO OF BIOTECHNOLOGY FIRM ILLUMINA INC.  Full Article

Illumina reports Q3 GAAP earnings per share $1.11
Tuesday, 24 Oct 2017 04:05pm EDT 

Oct 25 (Reuters) - Illumina Inc :Illumina reports financial results for third quarter of fiscal year 2017.Q3 non-GAAP earnings per share $1.11.Q3 GAAP earnings per share $1.11.Q3 revenue $714 million versus I/B/E/S view $692.8 million.Sees fy 2017 non-GAAP earnings per share $3.73 to $3.78.Sees fy 2017 revenue up about 13 percent.Q3 earnings per share view $0.99 -- Thomson Reuters I/B/E/S.Illumina Inc - ‍for fiscal 2017 company now projects GAAP earnings per diluted share attributable to Illumina stockholders of $5.56 to $5.61​.Fy2017 earnings per share view $3.65, revenue view $2.68 billion -- Thomson Reuters I/B/E/S.  Full Article

Illumina files new patent infringement suit against Premaitha Health Plc
Thursday, 7 Sep 2017 09:00am EDT 

Sept 7 (Reuters) - Illumina Inc :Illumina Inc - ‍filed new patent infringement suit against Premaitha Health Plc in High Court of Justice, Chancery Division, Patents Court in UK.  Full Article

Illumina Q2 earnings per share $0.87
Tuesday, 1 Aug 2017 04:05pm EDT 

Aug 1 (Reuters) - Illumina Inc :Illumina reports strong financial results for second quarter of fiscal year 2017.Q2 non-GAAP earnings per share $0.82.Q2 GAAP earnings per share $0.87.Q2 revenue $662 million versus I/B/E/S view $642.4 million.Q2 earnings per share view $0.69 -- Thomson Reuters I/B/E/S.Illumina Inc says for fiscal 2017, company has updated its projections to approximately 12% revenue growth.Illumina Inc says for fy 2017 gaap earnings per diluted share attributable to illumina stockholders is forecasted to be $5.36 to $5.46.Illumina Inc says expects FY 2017 non-GAAP earnings per diluted share attributable to illumina stockholders of $3.60 to $3.70.Fy2017 earnings per share view $3.63, revenue view $2.65 billion -- Thomson Reuters I/B/E/S.  Full Article

Inno-Gene says units reach agreement with Illumina over patent dispute
Monday, 26 Jun 2017 02:54am EDT 

June 26 (Reuters) - INNO-GENE SA ::SAID ON FRIDAY THAT ITS UNITS, CENTRUM BADAN DNA SP. Z O.O AND MEDGENETIX SP. Z O.O., REACHED SETTLEMENT WITH THE COMPANY ILLUMINA INC. <<>> CONCERNING VIOLATION OF INTELLECTUAL PROPERTY OF ITS PATENT.SAID ITS UNITS AFFIRMED VALIDITY OF ILLUMINA INC. PATENT AND ILLUMINA INC. WILL WITHDRAW THE LAWSUIT.  Full Article

HTG Molecular amends, restates IVD test development, component supply agreement with Illumina
Monday, 5 Jun 2017 08:00am EDT 

June 5 (Reuters) - HTG Molecular Diagnostics Inc ::Amended and restated its IVD test development and component supply agreement with Illumina.HTG Molecular Diagnostics - agreement extends term, increases number of in-vitro diagnostic test kits that may be developed with Illumina sequencing technology.  Full Article

HTG Molecular Diagnostics says ‍entered amended and restated development and component supply agreement with illumina
Friday, 2 Jun 2017 06:03pm EDT 

June 2 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics - ‍entered amended and restated development and component supply agreement with illumina, inc effective may 31 - sec filing​.HTG Molecular Diagnostics - ‍co required to pay illumina up to $0.6 million upon achievement of specified regulatory milestones relating to ivd test kits​.HTG Molecular Diagnostics- agreed to pay illumina single digit percent royalty on net sales of ivd test kits co commercializes pursuant to restated deal ‍​.HTG Molecular-‍filed amendment to prospectus supplement to increase amount of stock that may be offered in atm offering under sales deal to $40 million.  Full Article

Illumina reports Q1 GAAP earnings per share $2.52
Tuesday, 25 Apr 2017 04:05pm EDT 

April 25 (Reuters) - Illumina Inc :Illumina reports financial results for first quarter of fiscal year 2017.Q1 non-GAAP earnings per share $0.64.Q1 GAAP earnings per share $2.52.Q1 revenue $598 million versus I/B/E/S view $589.8 million.Q1 earnings per share view $0.64 -- Thomson Reuters I/B/E/S.Sees Q2 revenue up about 7 percent.Illumina inc - for fiscal 2017, company is projecting 10% to 12% revenue growth.Illumina Inc - for fiscal 2017, sees gaap earnings per diluted share attributable to illumina stockholders of $5.26 to $5.36.Sees 2017 non-GAAP earnings per diluted share attributable to illumina stockholders of $3.60 to $3.70.Sees Q2 GAAP earnings per diluted share attributable to illumina stockholders of $0.56 to $0.61.Sees Q2 non-GAAP earnings per diluted share attributable to illumina stockholders of $0.65 to $0.70.Q2 earnings per share view $0.87, revenue view $642.5 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $3.65, revenue view $2.65 billion -- Thomson Reuters I/B/E/S.  Full Article

Illumina CEO Francis Desouza's FY 2016 total compensation was $8.4 mln - SEC Filing
Thursday, 30 Mar 2017 05:32pm EDT 

Illumina Inc : CEO Francis A. Desouza's FY 2016 total compensation was $8.4 million versus $5.4 million in FY 2015 - SEC Filing .Executive chairman Jay Flatley's FY 2016 total compensation was $3.0 million versus $9.2 million in FY 2015.  Full Article

Illumina says board increased size of board from 10 to 11 members
Tuesday, 21 Feb 2017 01:42pm EST 

Illumina Inc :On February 18, 2017, board increased size of board from ten to 11 members and elected John Thompson to board - SEC filing.  Full Article

BRIEF-Disney Board Elects Oracle And Illumina CEOs As Directors

* DISNEY BOARD ELECTS ORACLE’S SAFRA CATZ AND ILLUMINA’S FRANCIS A. DESOUZA AS DIRECTORS